Drug ID: | NPD2791 |
Drug Name: | roquinimex |
Molecular Formula: | C18H16N2O3 |
Canonical SMILES: | CN(C(=O)c1c(O)c2ccccc2n(c1=O)C)c1ccccc1 |
Standard InCHI: | InChI=1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3 |
Standard InCHIKey: | SGOOQMRIPALTEL-UHFFFAOYSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB015603 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 308.12 |
ALogP | -1.3559 |
MLogP | 2.89 |
XLogP | 4.34 |
HDA | 5 |
HBD | 1 |
Rotatable Bonds | 6 |
TPSA | 60.85 |
RO5 Violation | 0 |